Thursday, May 26th, 2016 - Life Science Industry Research

The Report, Report, “Abilify- Drug Insights, 2016” highlights the Abilify marketed details, pipeline status and the Global API Manufacturers along with the location. The report covers the Global Market Assessment of the Abilify covering the total sales estimation and also provides the Abilify sales performance during the historical period and forecast period to 2018. Report also covers the detailed clinical assessment of Abilify, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, Report provides the SWOT analysis for the Abilify.

Complete Report Spread across 35 pages with 10 Figures Now Available. Get DISCOUNT on This Report http://www.lifescienceindustryresearch.com/discount?rname=81314

Scope

  • A review of the Abilify based on information derived from company and industry-specific sources
  • Coverage of the Marketed data of the Abilify on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
  • Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Abilify with location details
  • Patent Expiry Timeline and Exclusivity Details
  • Route of Synthesis of the API
  • Global Forecasted Sales Figure to 2018
  • Qualitative and quantitative assessment of market space
  • SWOT Analysis

Reasons to buy

  • Evaluate the marketing status and exclusivity details of Abilify to exploit opportunities for generic drug development opportunities.
  • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Abilify.
  • API intelligence over Abilify and gaining primary intelligence over Active Ingredients manufacturers across the globe.
  • Understanding the chemical route of synthesis of Abilify.
  • Uncovering opportunities in the rapidly growing the US market
  • Stay ahead of competition by understanding the changing competitive landscape
  • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
  • Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
  • Obtain sales forecast for currently marketed drug for to 2018

Order a Copy of This Report at http://www.lifescienceindustryresearch.com/purchase?rname=81314

Table of Contents

1. Indication Overview

2. Uniflox Overview

3 Global Sales Assessment

4 Product Description

5 Marketed Details

6 Patent Information

7 Route of Synthesis

8 Global API Manufacturers Assessment

9 Generic Players

10 The Pipeline Coverage

11 Clinical Trials Information

12 Company Profile

13 SWOT Analysis

14 References

15 Appendix

16 Methodology

17 Consulting Services

Contact Profile

Life Science Industry Research


Life Science Industry Research brings to you to the latest reports in market research on Biotechnology, Diagnostics, Healthcare, Medical Devices and Pharmaceuticals segments from leading research publishers across the globe. These reports also cover data and information on sub-segments and sectors under these life sciences categories.


Ritesh Tiwari
P: + 1 888 391 5441
W: www.lifescienceindustryresearch.com/

Keywords

Abilify, Abilify Drugs, Pharmaceuticals, Life Science, Drugs, Abilify Market, Abilify Industry

Categories

Newsrooms

Sharing

More Formats